Skip to main content
Skip to "About government"
Skip to section menu
Language selection
Français
fr
/
Gouvernement du Canada
Search
Search Canada.ca
Search
Menu
Main
Menu
Jobs and the workplace
Immigration and citizenship
Travel and tourism
Business and industry
Benefits
Health
Taxes
Environment and natural resources
National security and defence
Culture, history and sport
Policing, justice and emergencies
Transport and infrastructure
Canada and the world
Money and finances
Science and innovation
Manage life events
You are here:
Canada.ca
Departments and agencies
Health Canada
Drugs and health products
Biologics, radiopharmaceuticals and genetic therapies
Health Canada Scientific/Expert Advisory Panels
Expert Advisory Panel on Avastin
Report of the Expert Advisory Panel on the use of Avastin in metastatic breast cancer
Membership List and Biographies
Terms of Reference
Summary of Expertise, Experience, and Affiliations
Page details
Date modified:
2017-05-04
Section Menu
Health Canada Scientific/Expert Advisory Panels
Expert Advisory Panel on Avastin
Membership List and Biographies: Expert Advisory Panel on the use of Avastin in Metastatic Breast Cancer (EAP-AmBC) - Health Canada
Summary of Expertise, Experience, Affiliations and Interests: Expert Advisory Panel on the use of Avastin in Metastatic Breast Cancer (EAP-AmBC) - Health Canada
Terms of Reference: Expert Advisory Panel on the use of Avastin in Metastatic Breast Cancer (EAP-AmBC) - Health Canada
Expert Advisory Panel on Prochymal
